Individuals With Cancer and an ICD Receive More Aggressive End-of-Life Care
By Elana Gotkine HealthDay Reporter
FRIDAY, Jan. 10, 2025 -- Older cancer decedents with an implantable cardioverter defibrillator (ICD) receive more aggressive end-of-life care, according to a study published online Nov. 14 in Cancer.
Megan A. Mullins, Ph.D., M.P.H., from the UT Southwestern Medical Center in Dallas, and colleagues examined ICD prevalence and the association with aggressive end-of-life care among individuals with breast, colorectal, and pancreatic cancer. The analyses included 37,306 Medicare beneficiaries aged 66 years and older with stage 3 or 4 cancer who died between 2005 and 2016.
The researchers found that 6 percent of the cancer decedents had an ICD. More individuals with versus without an ICD died in the hospital (31 versus 25 percent). Overall, 46 percent of individuals with an ICD had device programming or interrogation visits that could have provided an opportunity for device discussion. Other than chemotherapy, ICD presence was associated with higher odds of every indicator of aggressive end-of-life care in adjusted models.
"Though individuals with cancer who had an ICD were more likely to receive all indicators of aggressive end‐of‐life care other than chemotherapy, nearly half of the individuals with an ICD had a device programming encounter in their last six months of life that could serve as an opportunity to discuss goals of care and device deactivation," the authors write.
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Race Definitions Have Limited Impact on Cancer Rates in Whites, Blacks, Asians
MONDAY, July 21, 2025 -- Race definitions have limited impact on cancer rates for Whites, Blacks, and Asians, but do impact rates in multiracial individuals, according to a study...
Updated Guidance Improves Staging of HPV-Positive Oropharyngeal Cancer
MONDAY, July 21, 2025 -- Version nine of the American Joint Committee on Cancer (AJCC) and Union for International Cancer Control staging system (AJCC9V) human papillomavirus...
Increased Risk for CVD Seen for Women With Premenstrual Disorders
THURSDAY, July 17, 2025 -- Women with premenstrual disorders (PMDs) have an increased risk for cardiovascular diseases (CVDs), according to a study published online July 11 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.